Faculty Opinions recommendation of Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.

2018 ◽  
Author(s):  
Francesco Maisano
Keyword(s):  
High Risk ◽  
Aortic Valve ◽  
Aortic Stenosis ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Intermediate Risk ◽  
Transcatheter Aortic Valve ◽  
Risk Patients ◽  
Sapien 3

Transcatheter Aortic Valve Replacement

2019 ◽  
pp. 175-184
Author(s):  
Melanie Mei Liu ◽  
Georg Burkhard Mackensen
Keyword(s):  
High Risk ◽  
Aortic Valve ◽  
Aortic Stenosis ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Intraoperative Imaging ◽  
Intermediate Risk ◽  
Transcatheter Aortic Valve ◽  
Risk Patients

Transcatheter aortic valve replacement (TAVR) has revolutionized the management of patients with severe symptomatic aortic stenosis deemed high risk for surgery or inoperable, and its use has recently expanded to the treatment of intermediate-risk patients with severe symptomatic aortic stenosis as well as high-risk patients with a failing aortic valve bioprosthesis. As a key member of the interdisciplinary heart valve team involved in the care of the TAVR patient, the anesthesiologist must be familiar with the currently available devices, procedural steps, and intraoperative imaging requirements in order not only to provide the appropriate level of anesthesia and analgesia for any given patient and procedure but also to anticipate and treat the hemodynamic changes and possible complications that accompany it.

scholarly journals Managing Stroke During Transcatheter Aortic Valve Replacement

2017 ◽  
Vol 12 (01) ◽  
pp. 25 ◽  
Author(s):  
Florian Hecker ◽  
Mani Arsalan ◽  
Thomas Walther ◽  
◽  
◽  
...  
Keyword(s):  
High Risk ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Elevated Risk ◽  
Intermediate Risk ◽  
Surgical Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Risk Patients

Transcatheter aortic valve replacement (TAVR) has become the default treatment option for high-risk patients with aortic stenosis and an alternative to surgical aortic valve replacement in intermediate-risk patients. There are, however, concerns regarding strokes during TAVR. Reported stroke rates vary strongly depending on the type of study, stroke definition, cohort and study period. Furthermore, stroke after TAVR occurs in three distinct phases: 1) early high-risk, directly procedure related; 2) elevated risk interval between day 2 and day 30; 3) late hazard interval. Each of these phases is caused by the different aetiologies of stroke. This review summarises the different aetiologies and potential strategies for managing stroke during TAVR.

Sign in / Sign up

Export Citation Format

Share Document